Core Insights - Balchem Corporation reported solid financial results for the second quarter of 2024, with record earnings from operations and adjusted EBITDA, driven by strong performance in the Human Nutrition and Health and Specialty Products segments [1][2][12] Financial Performance - Quarterly net sales reached $234.1 million, a 1.2% increase compared to the same quarter last year [2][4] - Adjusted EBITDA was a record $62.3 million, reflecting a 5.0% increase year-over-year [2][5] - GAAP net earnings were $32.1 million, up 6.5% from the prior year quarter, with earnings per share increasing to $0.98 from $0.93 [2][5] - Free cash flow for the quarter was $38.4 million, supported by strong cash flows from operations of $45.0 million [2][11] Segment Performance - The Human Nutrition & Health segment generated sales of $147.9 million, a 9.0% increase, with earnings from operations rising 21.3% to $33.4 million [6][12] - The Animal Nutrition & Health segment saw a decline in sales to $49.6 million, a decrease of 19.2%, with earnings from operations dropping 64.9% to $2.7 million [7][12] - The Specialty Products segment reported sales of $35.1 million, a 7.2% increase, with earnings from operations reaching a record $11.2 million, up 20.8% [8][12] Cash Flow and Debt Management - Strong cash flows allowed the company to repay $35.0 million of revolving debt, reducing net debt to $202.8 million, with a leverage ratio of 0.9 times [3][11] - The company maintained a cash balance of $63.7 million as of June 30, 2024 [11][20] Strategic Initiatives - Balchem launched a new product, Optifolin+®, aimed at supporting cellular health, enhancing its portfolio in the minerals and nutrients market [3][12] - The company continues to focus on strategic growth initiatives while delivering solid financial results [3][12]

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to capitalize on established price movements for profitable trades [1] Company Overview: Blachem (BCPC) - Blachem currently holds a Momentum Style Score of A and a Zacks Rank of 1 (Strong Buy) [2] - Stocks rated Zacks Rank 1 and 2 with Style Scores of A or B tend to outperform the market over the following month [2] Price Performance - BCPC shares have increased by 3.47% over the past week, outperforming the Zacks Chemical - Specialty industry, which rose by 3.4% [3] - Over the past month, BCPC's price change is 9.17%, significantly higher than the industry's 1.91% [3] - In the last quarter, BCPC shares rose by 16.85%, and over the past year, they gained 28.57%, compared to the S&P 500's increases of 11.69% and 26.6%, respectively [4] Trading Volume - BCPC's average 20-day trading volume is 122,920 shares, indicating a bullish sign when combined with rising stock prices [4] Earnings Outlook - In the past two months, one earnings estimate for BCPC has increased, while none have decreased, raising the consensus estimate from $3.86 to $3.89 [5] - For the next fiscal year, one estimate has moved upwards with no downward revisions during the same period [5] Conclusion - Given the strong performance metrics and positive earnings outlook, BCPC is positioned as a 1 (Strong Buy) stock with a Momentum Score of A, making it a compelling near-term investment option [6]

Company Overview - Balchem Corporation develops, manufactures, and markets specialty ingredients aimed at improving health and well-being across various industries globally [3] - The company operates through three business segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products [3] - The Human Nutrition & Health segment focuses on customized food and beverage ingredient systems and key nutrients for food, supplement, and pharmaceutical applications [3] - The Animal Nutrition & Health segment supplies products to various animal health markets [3] - Specialty Products offers specialty-packaged chemicals for healthcare and other industries, as well as chelated minerals for the micronutrient agricultural market [3] Upcoming Events - A conference call is scheduled for July 26, 2024, at 11:00 AM ET to review second quarter results [1] - Second quarter results will be published before the market opens on the same day [1] - The press release and financial exhibits will be available on the company website prior to the conference call [1] Conference Call Details - Participants can join the conference call by calling toll-free 1-877-407-8289 or local dial-in 1-201-689-8341, five minutes before the start time [2] - A replay of the conference call will be available three hours after its conclusion until the end of the day on August 9, 2024 [2] - To access the replay, dial 1-877-660-6853 or local dial-in 1-201-612-7415, using conference ID 13747779 [2]

MONTVALE, N.J., July 12, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC) today announced that a conference call will be held on Friday, July 26, 2024, at 11:00 AM Eastern Time (ET) to review second quarter results. Ted Harris, Chairman of the Board, President and CEO, and Martin Bengtsson, CFO, will host the call. Second quarter results will be published prior to the market opening on Friday, July 26, 2024. The press release, and its accompanying financial exhibits, will also be available on the ...

Core Viewpoint - Growth investors are increasingly focusing on stocks with above-average financial growth, and Blachem (BCPC) is highlighted as a strong candidate due to its favorable growth metrics and Zacks Rank [1][2]. Earnings Growth - Blachem's historical EPS growth rate is 0.8%, but projected EPS growth for this year is 16%, surpassing the industry average of 14.9% [3]. Cash Flow Growth - The year-over-year cash flow growth for Blachem is currently at 4%, significantly higher than the industry average of -2.6%. The company's annualized cash flow growth rate over the past 3-5 years is 2.8%, compared to the industry average of 1.1% [4]. Earnings Estimate Revisions - The current-year earnings estimates for Blachem have been revised upward, with the Zacks Consensus Estimate increasing by 0.8% over the past month [5]. Overall Positioning - Blachem has achieved a Zacks Rank 1 (Strong Buy) and a Growth Score of B, positioning it well for potential outperformance in the market [6][7].

MONTVALE, N.J., June 26, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at the CJS Securities 24th Annual New Ideas Summer Conference on July 10, 2024. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer and Allison Baurichter, Senior Director Investor Relations will present at the conference. About Balchem Corporation Balchem C ...

Company Overview - Balchem Corporation is a global specialty ingredient manufacturer focused on health and nutrition markets [2] - The company operates through three business segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products [2] Business Segments - The Human Nutrition & Health segment provides customized food and beverage ingredient systems and key nutrients for food, supplement, and pharmaceutical applications [2] - The Animal Nutrition & Health segment supplies products to various animal health markets [2] - Specialty Products segment offers specialty-packaged chemicals for healthcare and other industries, as well as chelated minerals for the micronutrient agricultural market [2] Upcoming Events - Balchem Corporation will present at the CJS Securities 24th Annual New Ideas Summer Conference on July 10, 2024 [1] - Key executives including Ted Harris (Chairman, President, and CEO), Martin Bengtsson (CFO), and Allison Baurichter (Senior Director Investor Relations) will represent the company at the conference [1]

MONTVALE, N.J., May 29, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at the Wells Fargo Industrials Conference on June 12, 2024. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer, and Allison Baurichter, Senior Director Investor Relations will present at the conference. About Balchem Corporation Balchem Corporation develops, ...

MONTVALE, N.J., May 29, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at the Wells Fargo Industrials Conference on June 12, 2024. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer, and Allison Baurichter, Senior Director Investor Relations will present at the conference. About Balchem Corporation Balchem Corporation develops ...

MONTVALE, N.J., May 21, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will attend the Deutsche Bank Global Consumer Conference on June 4, 2024. Ted Harris, Chairman of the Board, President and Chief Executive Officer, and Martin Bengtsson, Chief Financial Officer will attend the conference. About Balchem Corporation Balchem Corporation develops, manufactures and markets specialty ingredients that improv ...